Home > News > Adapting to a new normal: Sakura Finetek Japan will continue to support customers in histopathology

Adapting to a new normal: Sakura Finetek Japan will continue to support customers in histopathology


We continue to express our heartfelt gratitude to the medical community and non-medical support staff who work tirelessly to care for patients, to the employees of key infrastructure industries who risk their well-being to help us maintain our quality of life and to the families of these courageous individuals. We pray that this challenging situation will improve soon and we pledge to do our part as individuals and as an organization to help curb the spread of COVID-19.

Although the state of emergency in Japan was fully lifted on May 25, Sakura Finetek Japan will continue to implement infection prevention measures in light of concerns about a second and third wave of infections.

In line with the new lifestyle guidelines recommended by the Japanese government expert council, we will be adjusting our business activities to a new normal. We aim to make full use of online communication tools to continue to provide customers with valuable information and quality services.

Infection Control and Business Continuity Policy
1. Infection control – we aim to protect the lives of our employees and their families and prevent the spread of COVID-19.
2. Business continuity – we will continue to serve and support the needs of histopathology labs, in accordance with our mission of “Advancing Cancer Diagnostics”.

Measures to Combat the Spread of COVID-19
1. We appreciate your understanding regarding the canceling of face-to-face visits or meetings. We respect your decision and the decision of our employees to cancel visits or meetings due to infection concerns.
2. All Sakura Finetek Japan employees are working from home and no domestic/overseas business travel is permitted. However, Sakura Finetek Japan takes its role in ensuring that your healthcare system remains operational very seriously and therefore urgent corrective maintenance will be executed. This rule is in force until further notice.

Production Status
Uninterrupted supply of histopathology equipment, consumables and services to you is our priority.
There is currently no serious delay in product delivery, but should this situation change, we will inform you immediately.

Stay healthy, stay safe.